Robeco Institutional Asset Management B.V. Ironwood Pharmaceuticals Inc Transaction History
Robeco Institutional Asset Management B.V.
- $66.7 Billion
- Q3 2025
A detailed history of Robeco Institutional Asset Management B.V. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 342,998 shares of IRWD stock, worth $528,216. This represents 0.0% of its overall portfolio holdings.
Number of Shares
342,998
Previous 370,334
7.38%
Holding current value
$528,216
Previous $266,000
68.8%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IRWD
# of Institutions
180Shares Held
159MCall Options Held
11.2MPut Options Held
0-
Black Rock Inc. New York, NY22.9MShares$35.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.2MShares$25 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$24.9 Million0.2% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$24.5 Million8.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.41MShares$12.9 Million0.01% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $236M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...